MedTech News
.................... by Andrew Celentano
Novel gene-based therapy helps nerves heal better after severe injury
“This study is the first to combine tissue nanotransfection (TNT) with nerve graft surgery, and the results are promising.
Sibel Health Receives FDA-Clearance for ANNE® Maternal, a Comprehensive and Fully Wireless Maternal-Fetal Monitoring Platform
Sibel Health today announced FDA 510(k) clearance of ANNE® Maternal, the world’s first fully wireless, comprehensive maternal-fetal monitoring platform.
InventHelp Inventors Develop New Ovulation Monitoring Device (RKH-979)
PITTSBURGH, April 8, 2026 /PRNewswire/ — “Our intention is to create a more accurate and exact wearable device to determine the onset of the female ovulation cycle and consequently when a female human or animal is most likely to become pregnant after insemination,” stated one of the two inventors, from Gainesville, Virginia, “hence the invention of the Ovulonics device. Our design would provide an easy, convenient and accurate detection time for human or animal
MedCAD’s AccuStride® Receives FDA 510(k) Clearance for New Anatomical Lower Leg Region Tib/Fib Solution
DALLAS, April 8, 2026 /PRNewswire/ — Dallas-based MedCAD has received FDA 510(k) clearance of its AccuStride® lower leg tibia and fibula system, making these patient-specific precision devices available to surgeons. The unique design of the custom-made planning and surgical guides will enable orthopedic surgeons to correct multiple related pathologies and osteotomies in a single procedure.
Daré’s CEO Wants Everyone To Invest in Women’s Health, Starting With Her Company
Sabrina Martucci Johnson wants everyone to invest in her women’s health biotech Daré Bioscience. That means you, dear reader.
FDA approves Endospan’s aortic stent
Research suggests that over 120,000 patients suffer from aortic arch disease in the US and Europe annually, but only around 25% of patients are diagnosed or treated.
Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter
Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial.
BD picks up CE mark for next-gen stent graft
BD (NYSE:BDX) announced today that it received CE mark approval for its Liverty TIPS stent graft system.